Hendri Wigunah

Hendri Wigunah

Startup Founder & Millenial Entrepreneur

Former Juno execs unveil Sana, a new cell engineering biotech that’s reportedly raising more than $800M – GeekWire

Hans Bishop at the 2016 GeekWire Summit. (GeekWire Photo / Dan DeLong) Former Juno Therapeutics executives Hans Bishop and Steve Harr have launched Sana Biotechnology, a startup focused on cell therapy, gene therapy and gene editing. Backed by ARCH Venture Partners, Flagship Pioneering and F-Prime Capital Partners, the new company is notable not just for… Continue reading

Home run exits happen stealthily for biotech – TechCrunch

Joanna Glasner Contributor More posts by this contributor Home run exits happen stealthily for biotech While tech waffles on going public, biotech IPOs boom Startup exit tallies commonly underestimate biotech returns. Unlike most tech deals, the biggest profits in bio often come long after an IPO or acquisition. Take Juno Therapeutics, a publicly traded cancer immunology… Continue reading